(1888PressRelease)
March 27, 2008 - Dr. Lebkowski will discuss the use human embryonic stem cells to advance technology for therapeutic applications. Human Embryonic Stem Cells (hESCs) can be propagated indefinitely yet differentiate to form all major lineages of somatic cells in the body. Protocols have been developed to differentiate at least 8 specific cell types from hESCs including oligodendrocyte progenitor cells, cardiomyocytes, hepatocytes, neural progenitors, dopaminergic neurons, osteoblasts, and endothelial cells; detailed phenotypic and in vitro functional studies have shown that these cells resemble their normal counterparts in human tissue. Several investigations have been performed showing that differentiated hESC populations survive, engraft, and function in animal models of human disease. Geron has made significant progress in each of these areas and will discuss the state-of-the-art development of hESC technology for human therapeutic use.
The conference also features presentations from other leading organizations such as FDA, Geron, Joint Committee on Health Care Financing (by Senator Richard Moore), Merck, MIT, Novartis, Pfizer, Sangamo BioSciences, Sanofi Aventis, Stemagen, UCSB, University of Van Amsterdam, Whitehead Institute, and many more. The full agenda is available online at www.gtcbio.com.
GTCbio’s 4th Stem Cell Research & Therapeutics will take place on April 17-18, 2008 in Boston, MA and will cover Stem Cell Biology, Adult Stem Cells, Embryonic Stem Cells, Differentiation of Stem Cells, Epigenomics & Reprogramming of Stem Cells, Regenerative Medicine & Therapeutics, Stem Cell Imaging, Regulatory Aspects & Funding Opportunities, Cancer Stem Cells, and Stem Cell Applications in Drug Discovery.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/userAgenda.aspx?id=120
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, nina.tran ( @ ) gtcbio dot com
